Delivery Order SPE2DB22D2214-SPE2DB26FS2LJ
- Not listed
- The Defense Logistics Agency awarded a $50,489.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of May 1, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military...
- The Defense Logistics Agency awarded a $21,852.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $73,368.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of September 10, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $15,373.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors with an ultimate completion date of August 19, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical procurement requirements for federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $36,944.08 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price, competitively awarded delivery order represents a direct fulfillment under the company's existing pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $26,698.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on June 4, 2025, with completion scheduled for June 5, 2025. This non-competitive, competitively awarded contract represents a small pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $77,429.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a single delivery order fulfilling federal pharmaceutical procurement needs through competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $11,972.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units). This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $18,925.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award was issued on July 14, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to supply...
- The Defense Logistics Agency awarded a delivery order valued at $8,347.93 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment for this pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2LJDelivery Order
The Defense Logistics Agency awarded a $43,711.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors (2 mL), with an ultimate completion date of October 21, 2025. This non-set-aside delivery order represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive contract vehicle enabling the company to supply a broad range of pharmaceutical products, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Through this prime contract vehicle, AmerisourceBergen fulfills medical procurement needs for various government healthcare systems including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.7k | 10/20/25 |